In last trading session, ARS Pharmaceuticals Inc (NASDAQ:SPRY) saw 1.77 million shares changing hands with its beta currently measuring 0.76. Company’s recent per share price level of $12.19 trading at $0.09 or 0.79% at ring of the bell on the day assigns it a market valuation of $1.20B. That closing price of SPRY’s stock is at a discount of -51.85% from its 52-week high price of $18.51 and is indicating a premium of 38.06% from its 52-week low price of $7.55.
For ARS Pharmaceuticals Inc (SPRY), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
ARS Pharmaceuticals Inc (NASDAQ:SPRY) trade information
Upright in the green during last session for gaining 0.79%, in the last five days SPRY remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $12.19 price level, adding 12.93% to its value on the day. ARS Pharmaceuticals Inc’s shares saw a change of 15.59% in year-to-date performance and have moved -9.60% in past 5-day. ARS Pharmaceuticals Inc (NASDAQ:SPRY) showed a performance of -18.65% in past 30-days.
Wall Street analysts have assigned a consensus price target of 22 to the stock, which implies a rise of 44.59% to its current value. Analysts have been projecting 18 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would drop -47.66% in reaching the projected high whereas dropping to the targeted low would mean a loss of -47.66% for stock’s current value.
ARS Pharmaceuticals Inc (NASDAQ:SPRY)’s Major holders
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is the top institutional holder at SPRY for having 11.08 million shares of worth $94.27 million. And as of 2024-06-30, it was holding 11.4409 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 10.86 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.2168 of outstanding shares, having a total worth of $92.43 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 1.99 shares of worth $24.28 million or 2.03% of the total outstanding shares. The later fund manager was in possession of 1.3 shares on Mar 31, 2025, making its stake of worth around $15.91 million in the company or a holder of 1.33% of company’s stock.
